Smith & Nephew SNATS Gross Margin 2011-2025 | SNN
Current and historical gross margin for Smith & Nephew SNATS (SNN) over the last 10 years. The current gross profit margin for Smith & Nephew SNATS as of June 30, 2025 is %.
| Smith & Nephew SNATS Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2014-12-31 | $4.62B | $3.46B | 74.83% |
| 2014-09-30 | $4.54B | $3.40B | 74.77% |
| 2014-06-30 | $4.42B | $3.31B | 74.92% |
| 2014-03-31 | $4.35B | $3.25B | 74.73% |
| 2013-12-31 | $4.35B | $3.25B | 74.72% |
| 2013-09-30 | $4.25B | $3.16B | 74.21% |
| 2013-06-30 | $4.18B | $3.10B | 74.13% |
| 2013-03-31 | $4.13B | $3.07B | 74.16% |
| 2012-12-31 | $4.14B | $3.07B | 74.14% |
| 2012-09-30 | $4.17B | $3.09B | 74.17% |
| 2012-06-30 | $4.25B | $3.13B | 73.79% |
| 2012-03-31 | $4.29B | $3.16B | 73.57% |
| 2011-12-31 | $4.27B | $3.13B | 73.30% |
| 2011-09-30 | $4.23B | $3.10B | 73.32% |
| 2011-06-30 | $4.14B | $3.05B | 73.60% |
| 2011-03-31 | $4.02B | $2.97B | 73.87% |
| 2010-12-31 | $3.96B | $2.93B | 73.98% |
| 2010-09-30 | $3.96B | $2.91B | 73.57% |
| 2010-06-30 | $3.94B | $2.89B | 73.37% |
| 2010-03-31 | $3.90B | $2.85B | 72.99% |
| 2009-12-31 | $3.77B | $2.74B | 72.69% |
| 2009-09-30 | $3.67B | $2.68B | 72.97% |
| 2009-06-30 | $3.68B | $2.66B | 72.32% |
| 2009-03-31 | $3.76B | $2.70B | 71.96% |
| 2008-12-31 | $3.80B | $2.72B | 71.67% |
| 2008-09-30 | $3.81B | $2.65B | 69.62% |
| 2008-06-30 | $3.72B | $2.61B | 70.08% |
| 2008-03-31 | $3.54B | $2.48B | 70.08% |
| 2007-12-31 | $3.37B | $2.38B | 70.50% |
| 2007-09-30 | $3.17B | $2.26B | 71.26% |
| 2007-06-30 | $3.01B | $2.15B | 71.60% |
| 2007-03-31 | $2.88B | $2.08B | 72.33% |
| 2006-12-31 | $2.78B | $2.01B | 72.33% |
| 2006-09-30 | $2.68B | $2.00B | 74.49% |
| 2006-06-30 | $2.61B | $1.94B | 74.38% |
| 2006-03-31 | $2.58B | $1.91B | 74.12% |
| 2005-12-31 | $2.56B | $1.90B | 74.29% |
| 2005-09-30 | $2.59B | $1.95B | 75.30% |
| 2005-06-30 | $2.57B | $1.94B | 75.26% |
| 2005-03-31 | $2.47B | $1.86B | 75.14% |
| 2004-12-31 | $2.40B | $1.79B | 74.53% |
| 2004-09-30 | $2.24B | $1.78B | 79.61% |
| 2004-06-30 | $2.11B | $1.81B | 85.73% |
| 2004-03-31 | $2.04B | $1.89B | 92.55% |
| 2003-12-31 | $1.93B | $1.93B | 100.00% |
| 2003-06-30 | $2.39B | $2.39B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $13.952B | $5.810B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.079B | 26.17 |
| EssilorLuxottica (ESLOY) | France | $171.331B | 0.00 |
| Boston Scientific (BSX) | United States | $152.232B | 34.81 |
| Stryker (SYK) | United States | $138.522B | 27.50 |
| Medtronic (MDT) | Ireland | $122.971B | 17.34 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.219B | 0.00 |
| Agilent Technologies (A) | United States | $41.624B | 26.94 |
| ResMed (RMD) | United States | $35.677B | 24.69 |
| GE HealthCare Technologies (GEHC) | United States | $33.321B | 15.94 |
| Koninklijke Philips (PHG) | Netherlands | $27.607B | 18.03 |
| Insulet (PODD) | United States | $23.404B | 72.64 |
| Terumo (TRUMY) | Japan | $22.638B | 25.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.819B | 11.11 |
| Baxter (BAX) | United States | $9.495B | 7.66 |
| Sunny Optical Technology (SNPTF) | China | $9.361B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.447B | 30.37 |
| Demant (WILYY) | Denmark | $7.346B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.515B | 10.71 |
| Haemonetics (HAE) | United States | $3.440B | 15.31 |
| ICU Medical (ICUI) | United States | $3.370B | 21.40 |
| Envista Holdings (NVST) | United States | $3.190B | 18.30 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.886B | 13.16 |
| LeMaitre Vascular (LMAT) | United States | $2.006B | 40.38 |
| Perrigo (PRGO) | Ireland | $1.896B | 4.75 |
| Phibro Animal Health (PAHC) | United States | $1.828B | 18.26 |
| AtriCure (ATRC) | United States | $1.636B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.450B | 9.32 |
| Neogen (NEOG) | United States | $1.389B | 26.62 |
| Curaleaf Holdings (CURLF) | Canada | $1.385B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.287B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.245B | 18.02 |
| Tilray Brands (TLRY) | Canada | $1.213B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.195B | 52.36 |
| BioLife Solutions (BLFS) | United States | $1.159B | 343.86 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.931B | 0.00 |
| InMode (INMD) | Israel | $0.896B | 10.12 |
| Valneva SE (VALN) | France | $0.778B | 0.00 |
| Surmodics (SRDX) | United States | $0.595B | 0.00 |
| Omeros (OMER) | United States | $0.558B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.495B | 17.03 |
| CeriBell (CBLL) | United States | $0.479B | 0.00 |
| Evolus (EOLS) | United States | $0.468B | 0.00 |
| SNDL (SNDL) | Canada | $0.441B | 0.00 |
| BillionToOne (BLLN) | $0.402B | 0.00 | |
| Cresco Labs (CRLBF) | United States | $0.344B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.340B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Cerus (CERS) | United States | $0.311B | 0.00 |
| Brainsway (BWAY) | Israel | $0.308B | 52.53 |
| Sanuwave Health (SNWV) | United States | $0.283B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.257B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.256B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.244B | 143.67 |
| Viemed Healthcare (VMD) | United States | $0.243B | 19.36 |
| High Tide (HITI) | Canada | $0.236B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.227B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Exagen (XGN) | United States | $0.204B | 0.00 |
| Organigram Global (OGI) | Canada | $0.204B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 15.64 |
| FitLife Brands (FTLF) | United States | $0.170B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.166B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.149B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.126B | 0.00 |
| Biote (BTMD) | United States | $0.115B | 5.04 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 13.25 |
| Sharps Technology (STSS) | United States | $0.087B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.049B | 20.77 |
| Nephros (NEPH) | United States | $0.047B | 33.85 |
| Cytosorbents (CTSO) | United States | $0.041B | 0.00 |
| Jin Medical (ZJYL) | China | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Modular Medical (MODD) | United States | $0.029B | 0.00 |
| Bonk (BNKK) | United States | $0.029B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.30 |
| Zynex (ZYXI) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Functional Brands (MEHA) | $0.003B | 0.00 | |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |